Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

BACKGROUND: For novel cancer treatments, effectiveness in clinical practice is not always aligned with clinical efficacy results. As such it is important to understand a treatment’s real-world effectiveness. We examined real-world population-based comparative effectiveness of second-line ipilimumab...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Dai, Wei Fang, Beca, Jaclyn M., Croxford, Ruth, Isaranawatchai, Wanrudee, Menjak, Ines B., Petrella, Teresa M., Mittmann, Nicole, Earle, Craig C., Gavura, Scott, Hanna, Timothy P., Chan, Kelvin K.W.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158109/
https://ncbi.nlm.nih.gov/pubmed/32293341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-06798-1
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki